Bearish signal on daily chart
Company has spent 2.98% of its operating revenues towards interest expenses and 16.46% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
Potential
Upside
1 Year
Target
BUY
Mean Recos by
9 Analysts
/10
Stock Score
Earnings | |
Fundamentals | |
Relative Valuation | |
Risk | |
Price Momentum |
Company has spent 2.98% of its operating revenues towards interest expenses and 16.46% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
Krishna Institute of Medical Sciences Ltd. share price moved up by 3.17% from its previous close of Rs 639.00. Krishna Institute of Medical Sciences Ltd. stock last traded price is 659.20
Share Price | Value |
---|---|
Today/Current/Last | 659.20 |
Previous Day | 639.00 |
PE Ratio (x) | 68.74 | ||||||||||
EPS - TTM (₹) | 9.61 | ||||||||||
MCap (₹ Cr.) | 26,431.18 | ||||||||||
Sectoral MCap Rank | 7 | ||||||||||
PB Ratio (x) | 10.57 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 2.00 | ||||||||||
Beta Beta
| - | ||||||||||
VWAP (₹) | 656.81 | ||||||||||
52W H/L (₹) |
1 Day | 3.17% |
1 Week | 2.99% |
1 Month | -0.23% |
3 Months | 23.11% |
1 Year | 70.56% |
3 Years | 161.23% |
5 Years | N.A. |
Current
Mean Recos by 9 Analysts
Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
---|---|---|---|---|
Strong Buy | 4 | 5 | 5 | 5 |
Buy | 4 | 3 | 3 | 3 |
Hold | 1 | 1 | 1 | 1 |
Sell | - | - | - | - |
Strong Sell | - | - | - | - |
# Analysts | 9 | 9 | 9 | 9 |
Employee & Interest Expense
Company has spent 2.98% of its operating revenues towards interest expenses and 16.46% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)Quarterly | Annual | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|---|
Total Income | 801.40 | 790.20 | 782.30 | 693.00 | 637.60 |
Total Income Growth (%) | 1.42 | 1.01 | 12.89 | 8.69 | 4.68 |
Total Expenses | 640.70 | 629.90 | 600.20 | 548.00 | 521.13 |
Total Expenses Growth (%) | 1.71 | 4.95 | 9.53 | 5.16 | 5.47 |
EBIT | 160.70 | 160.30 | 182.10 | 145.00 | 116.48 |
EBIT Growth (%) | 0.25 | -11.97 | 25.59 | 24.49 | 1.28 |
Profit after Tax (PAT) | 101.80 | 88.70 | 107.40 | 86.60 | 65.47 |
PAT Growth (%) | 14.77 | -17.41 | 24.02 | 32.27 | -8.87 |
EBIT Margin (%) | 20.05 | 20.29 | 23.28 | 20.92 | 18.27 |
Net Profit Margin (%) | 12.70 | 11.23 | 13.73 | 12.50 | 10.27 |
Basic EPS (₹) | 2.54 | 2.22 | 2.68 | 10.82 | 8.18 |
All figures in Rs Cr, unless mentioned otherwise
Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Total Assets | 5,736.00 | 3,852.02 | 2,941.30 | 1,907.35 | 1,436.15 |
Total Assets Growth (%) | 48.91 | 30.96 | 54.21 | 32.81 | 20.09 |
Total Liabilities | 3,317.20 | 1,758.78 | 1,003.34 | 496.71 | 559.96 |
Total Liabilities Growth (%) | 88.61 | 75.29 | 102.00 | -11.30 | -4.19 |
Total Equity | 2,418.80 | 2,093.24 | 1,937.96 | 1,410.64 | 876.20 |
Total Equity Growth (%) | 15.55 | 8.01 | 37.38 | 61.00 | 43.30 |
Current Ratio (x) | 0.83 | 1.21 | 1.61 | 1.83 | 1.62 |
Total Debt to Equity (x) | 0.89 | 0.57 | 0.32 | 0.12 | 0.33 |
Contingent Liabilities | 0.00 | 555.71 | 458.97 | 103.57 | 42.37 |
All figures in Rs Cr, unless mentioned otherwise
Increase in Cash from Investing
Company has used Rs 1116.2 cr for investing activities which is an YoY increase of 48.32%. (Source: Consolidated Financials)Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Net Cash flow from Operating Activities | 581.80 | 521.09 | 432.09 | 324.03 | 355.97 |
Net Cash used in Investing Activities | -1,116.20 | -752.56 | -615.60 | -411.52 | -354.18 |
Net Cash flow from Financing Activities | 543.10 | 216.76 | 88.34 | 61.00 | 9.82 |
Net Cash Flow | 9.10 | -14.72 | 35.98 | -26.50 | 11.62 |
Closing Cash & Cash Equivalent | 56.00 | 46.89 | 61.61 | 25.63 | 52.13 |
Closing Cash & Cash Equivalent Growth (%) | 19.43 | -23.89 | 140.35 | -50.83 | 28.67 |
Total Debt/ CFO (x) | 3.28 | 2.01 | 1.23 | 0.50 | 0.80 |
All figures in Rs Cr, unless mentioned otherwise
Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Return on Equity (%) | 17.98 | 16.96 | 20.14 | 23.98 | 23.29 |
Return on Capital Employed (%) | 13.01 | 14.91 | 18.92 | 27.38 | 26.90 |
Return on Assets (%) | 6.70 | 8.05 | 11.43 | 17.44 | 14.01 |
Interest Coverage Ratio (x) | 9.02 | 13.90 | 20.62 | 33.43 | 11.73 |
Asset Turnover Ratio (x) | 0.63 | 0.74 | 0.61 | 0.76 | 0.77 |
Price to Earnings (x) | 66.67 | 53.19 | 33.56 | 33.22 | - |
Price to Book (x) | 11.96 | 9.01 | 6.74 | 7.96 | - |
EV/EBITDA (x) | 33.97 | 27.14 | 19.03 | 20.59 | - |
EBITDA Margin (%) | 26.84 | 26.15 | 28.66 | 32.47 | 28.65 |
Bullish / Bearish signals for Krishna Instt of Medical Sciences basis selected technical indicators and moving average crossovers.
5 Day EMA Crossover
Bearish signal on daily chart
Appeared on: 20 May 2025
5D EMA: 642.66
Date | 7 days Gain/Loss % |
---|---|
14 May 2025 | -1.25% |
30 Apr 2025 | -3.71% |
24 Apr 2025 | -0.76% |
1 Apr 2025 | -14.58% |
26 Mar 2025 | -1.75% |
Average price decline of -2.46% within 7 days of Bearish signal in last 5 years
Heikin-Ashi Changeover
Bullish indication on daily chart
Prev. Close Price
643.00
LTP
659.20
On daily price chart, Heikin-Ashi candle changed from Red to Green
R1 | R2 | R3 | PIVOT | S1 | S2 | S3 | |
---|---|---|---|---|---|---|---|
Classic | 670.88 | 681.82 | 710.57 | 653.07 | 642.13 | 624.32 | 595.57 |
5 DAYS | 14 DAYS | 28 DAYS | |
---|---|---|---|
ATR | 23.79 | 24.85 | 25.55 |
Choose from Peers
Choose from Stocks
MF Ownership details are not available.
Meeting Date | Announced on | Purpose | Details |
---|---|---|---|
May 12, 2025 | May 02, 2025 | Board Meeting | Audited Results |
Mar 18, 2025 | Feb 17, 2025 | POM | - |
Feb 06, 2025 | Jan 27, 2025 | Board Meeting | Quarterly Results |
Nov 09, 2024 | Oct 25, 2024 | Board Meeting | Quarterly Results |
Aug 29, 2024 | Aug 07, 2024 | AGM | - |
Dividend announcements are not available.
All Types | Ex-Date | Record Date | Announced on | Details |
---|---|---|---|---|
Splits | Sep 13, 2024 | Sep 13, 2024 | Jun 28, 2024 | Split: Old FV10.0| New FV:2.0 |
Krishna Institute of Medical Sciences Ltd., incorporated in the year 1973, is a Small Cap company (having a market cap of Rs 25,568.88 Crore) operating in Hospitals & Allied Services sector. Krishna Institute of Medical Sciences Ltd. key Products/Revenue Segments include Income from Hospitality, Pharmaceutical Products and Other Operating Revenue for the year ending 31-Mar-2024. Show More
Bhaskara Rao Bollineni
Chairman & Managing DirectorAbhinay Bollineni
Executive Director & CEOAnitha Dandamudi
Whole Time DirectorAdwik Bollineni
Non Executive DirectorIndustry
Key Indices Listed on
Nifty 500, BSE 500, BSE 250 SmallCap Index, + 13 more
Address
D.No. 1-8-31/1,Minister Road,Secunderabad, Telangana - 500003
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.